| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 43.717 | 74.470 | 76.004 | 93.616 | 99.480 | 124.717 | 134.084 |
| Total Income - EUR | - | - | - | 43.718 | 74.472 | 76.006 | 93.619 | 99.483 | 124.720 | 134.088 |
| Total Expenses - EUR | - | - | - | 25.941 | 43.837 | 48.512 | 56.499 | 57.777 | 68.680 | 64.806 |
| Gross Profit/Loss - EUR | - | - | - | 17.777 | 30.636 | 27.494 | 37.120 | 41.706 | 56.040 | 69.282 |
| Net Profit/Loss - EUR | - | - | - | 17.340 | 29.891 | 26.787 | 36.203 | 40.732 | 54.962 | 65.340 |
| Employees | - | - | - | 4 | 4 | 4 | 4 | 5 | 5 | 4 |
Check the financial reports for the company - Dr. Oros Teodora S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 8.761 | 17.807 | 10.065 | 39.895 | 31.863 | 26.967 | 21.842 |
| Current Assets | - | - | - | 22.200 | 31.856 | 69.827 | 52.838 | 34.713 | 63.348 | 126.635 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 37 | 37 | 278 |
| Receivables | - | - | - | 6.001 | 8.366 | 27.796 | 19.853 | 27.095 | 26.487 | 58.396 |
| Cash | - | - | - | 16.199 | 23.490 | 42.031 | 32.985 | 7.581 | 36.824 | 67.961 |
| Shareholders Funds | - | - | - | 17.383 | 46.937 | 72.834 | 64.864 | 40.781 | 81.656 | 65.388 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 13.578 | 2.725 | 7.058 | 28.024 | 25.951 | 8.812 | 83.242 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Oros Teodora S.r.l.